ANGLE PLC's (LON:AGL) Andrew Newland (CEO) & Ian Griffiths (FD) pitch to investors at the Proactive One2One live virtual conference.
ANGLE is a world leading liquid biopsy company with sample-to-answer solutions.
ANGLE's proven patent protected platforms include a circulating tumor cell (CTC) harvesting technology and a downstream analysis system for cost effective, highly multiplexed analysis of nucleic acids and proteins.